Targeting mTOR in gastrointestinal cancer [ 2013 - 2014 ]

Research Grant

Researchers: Dr Yvonne Yeung (Principal investigator)

Brief description This research project will focus on new treatment targets for gastrointestinal malignancies, focusing on the mTOR pathway which is important in driving cancer cell growth. The mTOR inhibitor drug Everolimus will be used in colon and biliary tract cancers to look for novel biomarkers of response and resistance to treatment, using cancer cell lines and correlative analysis with data obtained from patients' tumour samples and clinical assessment in current trials.

Funding Amount $AUD 69,499.84

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship